div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails7jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails8jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails9jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=10Page 10button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=10 data-page=10 class=ts-thumb lazyload alt=Page 10: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails10jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=11Page 11button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=11 data-page=11 class=ts-thumb lazyload alt=Page 11: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails11jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=12Page 12button div class=ts-imageimg data-url=worldwide-in-june-2018-biocon-and-mylan-became-the-first-to-receive-approval-forhtmlpage=12 data-page=12 class=ts-thumb lazyload alt=Page 12: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails12jpg width=140 height=200 divdiv
